Pohlad Cos names Erryn Williams chief talent and diversity officer - Minneapolis / St Paul Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Operator
Good day and welcome to the 2020 Fourth Quarter Earning Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Aaron Hoffman. Please go ahead.
Aaron Hoffman
Vice President, Investor Relations
Good morning, everyone, and thank you for joining us today. I hope that all of you remain safe and healthy. On the call today, we have Chris Cartwright, President and Chief Executive Officer; and Todd Cello, Executive Vice President and Chief Financial Officer. We posted our earnings release and slides to accompany this call on the TransUnion Investor Relations website. Our earnings release and the accompanying slides include various schedules, which contain more detailed information about revenue, operating expenses and other items, as well as certain non-GAAP disclosures and financial measures along with the corresponding reconciliation of these non-GAAP financial measures to their most directly compar
TransUnion (TRU) Q4 2020 Earnings Call Transcript msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Biohaven Provides Update On ESG Practices
News provided by
Share this article
Share this article
NEW HAVEN, Conn., Feb. 8, 2021 /PRNewswire/ Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the Company or Biohaven ), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates today announced the advancement of several important steps that underscore the company s commitment to sound Environmental, Social and Governance ( ESG ) practices.
Maximizing long-term shareholder value and managing resources responsibly remains a key driving force for Biohaven s ESG strategy, with the Company dedicated to bringing innovative medicines forward for patients and to grow value for investors while maintaining an efficient and high-performing culture.